Quarterly report [Sections 13 or 15(d)]

Net Income (Loss) Per Share (Tables)

v3.26.1
Net Income (Loss) Per Share (Tables)
 3 Months Ended
Mar. 31, 2026
Net Income (Loss) Per Share [Abstract]  
Schedule of Basic and Diluted Net Loss Per Share

The following table sets forth the computation of basic and diluted net loss per share of common and preferred stock (in thousands, except share and per share data):

 

    Three Months Ended
March 31,		  
    2025     2026  
Basic net (loss) income per share            
Numerator:            
Net income (loss)   $ 570     $ (12,824 )
Less: Dividend to Series B preferred stockholders    
-
      
-
  
Net income attributable to participating securities     (60 )    
-
  
Net income (loss) attributable to common stockholders, basic     510       (12,824 )
                 
Denominator:                
Weighted-average shares outstanding used in computing net income (loss) per share attributable to common stockholders, basic     11,681,881       23,908,153  
Net income (loss)  per share attributable to common stockholders, basic   $ 0.04     $ (0.54 )
    Three Months Ended
March 31,		  
    2025     2026  
Diluted net loss  per share            
Numerator:            
Net income (loss)   $ 570     $ (12,824 )
Net income attributable to participating securities     (60 )    
-
  
Change in fair value of preferred stock warrant liability     (6,724 )    
-
  
Net loss attributable to common stockholders, diluted     (6,214 )     (12,824 )
                 
Denominator:                
Weighted-average shares outstanding used in computing net loss per share attributable to common stockholders, diluted     12,383,477       23,908,153  
Net loss per share attributable to common stockholders, diluted   $ (0.50 )   $ (0.54 )
Schedule of Outstanding Shares of Potentially Dilutive Securities

The following outstanding shares of potentially dilutive securities were excluded from the computation of diluted net loss per share for the periods presented because including them would have been antidilutive:

 

    Three Months Ended
March 31,		     Three Months Ended
March 31		  
    2025     2026  
             
Options to purchase common stock     1,364,579       2,033,114  
Warrants to purchase common stock     478,419       478,419  
Restricted stock units     2,177       3,677  
Common stock issuable upon conversion of Series B-2 convertible preferred stock     300,000      
-
  
Common stock issuable upon conversion of Series A-2 Prime convertible preferred stock     1,115,145       462,245  
Warrants to purchase convertible preferred stock     6,960,353       15,818,817  
Total     10,220,673       18,796,272